Suppr超能文献

病例报告:人工血管移植感染患者噬菌体治疗失败分析

Case report: Analysis of phage therapy failure in a patient with a prosthetic vascular graft infection.

作者信息

Blasco Lucia, López-Hernández Inmaculada, Rodríguez-Fernández Miguel, Pérez-Florido Javier, Casimiro-Soriguer Carlos S, Djebara Sarah, Merabishvili Maya, Pirnay Jean-Paul, Rodríguez-Baño Jesús, Tomás María, López Cortés Luis Eduardo

机构信息

Translational and Multidisciplinary Microbiology (MicroTM)-Biomedical Research Institute (INIBIC), University of A Coruña (UDC), A Coruña, Spain.

Microbiology Service, A Coruña Hospital (HUAC), University of A Coruña (UDC), A Coruña, Spain.

出版信息

Front Med (Lausanne). 2023 May 19;10:1199657. doi: 10.3389/fmed.2023.1199657. eCollection 2023.

Abstract

Clinical case of a patient with a multidrug-resistant prosthetic vascular graft infection which was treated with a cocktail of phages (PT07, 14/01, and PNM) in combination with ceftazidime-avibactam (CZA). After the application of the phage treatment and in absence of antimicrobial therapy, a new bloodstream infection (BSI) with a septic residual limb metastasis occurred, now involving a wild-type strain being susceptible to ß-lactams and quinolones. Clinical strains were analyzed by microbiology and whole genome sequencing techniques. In relation with phage administration, the clinical isolates of before phage therapy (HE2011471) and post phage therapy (HE2105886) showed a clonal relationship but with important genomic changes which could be involved in the resistance to this therapy. Finally, phenotypic studies showed a decrease in Minimum Inhibitory Concentration (MIC) to ß-lactams and quinolones as well as an increase of the biofilm production and phage resistant mutants in the clinical isolate of post phage therapy.

摘要

一名患有多重耐药性人工血管移植物感染的患者的临床病例,该患者接受了噬菌体鸡尾酒疗法(PT07、14/01和PNM)联合头孢他啶-阿维巴坦(CZA)治疗。在应用噬菌体治疗且未进行抗菌治疗后,发生了新的血流感染(BSI)并伴有脓毒性残肢转移,现在涉及一株对β-内酰胺类和喹诺酮类敏感的野生型菌株。通过微生物学和全基因组测序技术对临床菌株进行了分析。关于噬菌体给药,噬菌体治疗前(HE2011471)和噬菌体治疗后(HE2105886)的临床分离株显示出克隆关系,但存在重要的基因组变化,这些变化可能与对该治疗的耐药性有关。最后,表型研究表明,噬菌体治疗后的临床分离株对β-内酰胺类和喹诺酮类的最低抑菌浓度(MIC)降低,同时生物膜产生增加,且出现了噬菌体抗性突变体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e1/10235614/d7170830415d/fmed-10-1199657-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验